- Home
- MRCO vs ELMD Comparison
MRCO vs ELMD Comparison
Compare MRCO & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRCO | ELMD |
|---|---|---|
| Founded | 2025 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.8M | 226.4M |
| IPO Year | 2026 | 2010 |
Fundamental Metrics
Financial Performance| Metric | MRCO | ELMD |
|---|---|---|
| Price | $9.88 | $27.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $48.50 |
| AVG Volume (30 Days) | 33.2K | ★ 43.0K |
| Earning Date | N/A | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.94 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $54,716,000.00 |
| Revenue This Year | N/A | $12.71 |
| Revenue Next Year | N/A | $10.70 |
| P/E Ratio | ★ N/A | $20.85 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $9.85 | $23.01 |
| 52 Week High | $10.03 | $47.40 |
Technical Indicators
Market Signals| Indicator | MRCO | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.69 | 39.51 |
| Support Level | $9.86 | $26.03 |
| Resistance Level | $9.90 | $28.55 |
| Average True Range (ATR) | 0.02 | 0.81 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 16.67 | 24.33 |
Price Performance
Historical ComparisonAbout MRCO Mercator Acquisition Corp. Class A Ordinary Shares
Mercator Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures and markets airway clearance products that apply High Frequency Chest Wall Oscillation (HFCWO) therapy in pulmonary care for patients of all ages. The company markets its products in the U.S. to the homecare and hospital markets. Its product includes the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The company operates in a single segment: developing, manufacturing, and marketing medical equipment. The company generates revenue from Homecare, Hospital, Homecare Distributor, and Other.